Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

JNJ 100.35 +0.22 (0.22%)
price chart
Johnson & Johnson to open life science centres
Johnson & Johnson is to open four life science �innovation centres� as it decentralises decisions on investment and partnerships to boost productivity.
Johnson & Johnson sets up SF center  San Francisco Chronicle
Johnson & Johnson Announces Plans to Establish Innovation Centers  PR Newswire (press release)
Related articles »  
Lawyers in Risperdal case argue Johnson & Johnson's CEO should be called to ...
Johnson & Johnson's top executive should be forced to testify about claims that the company illegally marketed the antipsychotic drug Risperdal, which allegedly caused boys to grow breasts, lawyers for a teenager suing the drugmaker said in a court filing.
J&J's Alex Gorsky testify? Much too busy....on the other side of the ...  Philadelphia Inquirer (blog)
Related articles »  
Johnson & Johnson settles on first day of Philly Risperdal trial
A jury was picked and the trial was about to begin Monday morning in Philadelphia Common Pleas Court when Johnson & Johnson's Janssen Pharmaceuticals subsidiary settled a lawsuit with a Texas man who said he grew breasts as a child after being ...
J&J Sees Male Breasts And Quickly Settles Risperdal Suit  Forbes
J&J Settles Pa. Risperdal Lawsuit On Opening Day of Trial  Law360 (subscription)
Related articles »  
Johnson & Johnson Launches Be Vital Challenge to Reward College Student ...
NEW BRUNSWICK, N.J., Sept. 18, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) is launching a challenge to reward college student organizations for their effort in taking care of the world we share.
Related articles »  
Procter & Gamble Takes Over #11 Spot From Johnson & Johnson
But comparing market capitalization (factoring in those share counts) creates a true �apples-to-apples� comparison of the value of two stocks.
Lawyer Fights $10 Million Fee For "Cosmetic" Johnson And Johnson Settlement
Since this is a so-called derivative action filed on behalf of Johnson & Johnson itself, the settlement would actually cost their clients $10 million, on top of the millions of dollars the medical-products giant has already paid the government to ...
Johnson & Johnson - Life After The Patent Cliff?
Johnson & Johnson (NYSE:JNJ) saw the patents for its antibiotic, Levaquin (Floxin), and its ADHD/ADD drug, Concerta, expire in 2011.
Related articles »  
Johnson & Johnson Report: 54% of Hospitals Say Green Attributes Important in ...
More than one-third (35 percent) of hospitals surveyed switched suppliers to gain access to sustainable health-care products, according to a new report by Johnson & Johnson that finds hospitals are placing greater emphasis on �green� products used in ...
Future Impact of Environmental Scorecards, Hospital Global Purchasing ...  CSRwire.com (press release)
Related articles »  
Johnson & Johnson-Tied Company Illegally Tested Products On Humans With ...
FORTUNE -- On Nov. 16, 2011, Georgia Baddley, a 70-year-old woman living near Salt Lake City, received a shocking call from a special agent at the U.S.
Johnson & Johnson, Starbucks, 17 Other Companies Tell Congress to Extend ...
Starbucks, Johnson & Johnson, Sprint and 16 other companies have sent a letter to Congress, urging elected officials to extend the wind production tax credit (PTC) before it expires at the end of 2012.
Business Leaders Want Wind Power Tax Credit Extended  Triple Pundit
Related articles »